Literature DB >> 3805057

Giant-cell tumor of bone.

M Campanacci, N Baldini, S Boriani, A Sudanese.   

Abstract

Of 327 patients who had a giant-cell tumor of bone and were seen at the Istituto Rizzoli, 293 were treated at the Institute, and 280 of these were followed for two to forty-four years. The distribution according to sex and age of the patient and site of the tumor was similar to the distributions in major reports of large series. The tumor usually involved the metaphysis and the epiphysis, but was occasionally limited to the metaphysis, and in only 2 per cent of the patients was it adjacent to an open growth plate. The tumor on occasion invaded the articular space, also involving the ligaments and the synovial membrane. Extension to an adjacent bone through the joint occurred in 5 per cent of the tumors. Our radiographic grading, which is roughly comparable with the staging system of Enneking et al., was Grade I in 4 per cent, II in 74 per cent, and III in 22 per cent of 266 patients before treatment. A pathological fracture was apparent on the first radiograph in 9 per cent of the patients. In the 280 patients with adequate follow-up, 331 surgical procedures were performed. The rate of local recurrence was 27 per cent in the 151 intralesional procedures, 8 per cent in the 122 marginal excisions, and zero in the fifty-eight wide or radical procedures. These results did not correlate with the radiographic grade of the lesion. Of the fifty-one local recurrences that were seen after treatment at our institution, 90 per cent appeared in the first three years after surgery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3805057

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  331 in total

1.  Case report 757: Giant cell tumor of rib.

Authors:  R M Hanna; M Kyriakos; S F Quinn
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Giant-cell tumors of bone: an analysis of 87 cases.

Authors:  Yu-Ping Su; Wei-Ming Chen; Tain-Hsiung Chen
Journal:  Int Orthop       Date:  2004-05-25       Impact factor: 3.075

3.  Case report 740: Giant cell tumor of the hamate bone.

Authors:  E S Gould; J M Cooper; H G Potter; L B Lane; W Cruz-Vetrano; M Bansal; A Franchi
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

4.  Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis.

Authors:  Yu-Peng Liu; Kang-Hua Li; Bu-Hua Sun
Journal:  Clin Orthop Relat Res       Date:  2012-07-07       Impact factor: 4.176

5.  A novel approach to juxta-articular aggressive and recurrent giant cell tumours: resection arthrodesis using bone transport over an intramedullary nail.

Authors:  S Vidyadhara; Sharath K Rao
Journal:  Int Orthop       Date:  2006-05-25       Impact factor: 3.075

6.  Giant Cell Tumor of the Capitate Treated with Excision and Midcarpal Fusion.

Authors:  Ayat Allah Oufkir; Cyril Lazerges; Bertrand Coulet; Michel Chammas
Journal:  J Wrist Surg       Date:  2017-02-07

7.  Tumour and tumour-like lesions of the patella--a multicentre experience.

Authors:  J Singh; S L James; H M Kroon; K Woertler; S E Anderson; G Jundt; A M Davies
Journal:  Eur Radiol       Date:  2008-09-25       Impact factor: 5.315

8.  Giant cell tumor in children and adolescents.

Authors:  H E Schütte; W K Taconis
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

9.  Joint preservation after extensive curettage of knee giant cell tumors.

Authors:  Miguel A Ayerza; Luis A Aponte-Tinao; German L Farfalli; Carlos A Lores Restrepo; D Luis Muscolo
Journal:  Clin Orthop Relat Res       Date:  2009-06-10       Impact factor: 4.176

Review 10.  Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review.

Authors:  Teun Teunis; Sjoerd P F T Nota; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón
Journal:  Clin Orthop Relat Res       Date:  2014-01-28       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.